Focus
Novo Nordisk
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
